If you've spent any time researching peptides for recovery, body composition, or sleep, you've likely come across CJC-1295 and Ipamorelin, almost always mentioned together. That's because they're designed to work as a pair. Here's what each one does, why they're combined, and what to know before starting.
What Are CJC-1295 and Ipamorelin?
Both are synthetic peptides that work with your pituitary gland to support the release of growth hormone, but they do it through different mechanisms. CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue, it signals the pituitary to produce growth hormone. Ipamorelin is a growth hormone secretagogue, it triggers the pituitary to release that growth hormone. Used together, they're designed to produce a stronger, more coordinated release than either peptide alone.
Peptide Dispensarydispenses this as a combination pen: CJC-1295 (No DAC) 0.2mg (200mcg) with Ipamorelin 5.6mg, in a 2.4ml pen, dosed once daily.
How They Work Together
Because CJC-1295 stimulates production while Ipamorelin triggers release, the combination is designed to mimic your body's natural, pulsatile pattern of growth hormone release, most active during sleep, rather than causing an unnatural constant elevation. Ipamorelin is also considered selective, meaning it targets growth hormone release without significantly affecting cortisol or prolactin, hormones that older-generation secretagogues sometimes disrupted.
Dosing & Administration
This combination is typically administered as a daily subcutaneous injection, most commonly in the evening or before bed, to align with your body's natural overnight growth hormone release. Your prescriber will confirm the right schedule and duration for your goals.
What People Use CJC-1295 & Ipamorelin For
• Supporting muscle recovery and lean body composition alongside training
• General recovery and sleep quality support
• Skin and joint support as part of a broader wellness protocol
• Complementing an overall fitness or anti-aging regimen
Safety Considerations
Ipamorelin's selectivity for growth hormone release, without significantly triggering cortisol or prolactin, is one reason it's considered relatively well-tolerated compared to older secretagogues. That said, as with any peptide therapy, it should be used under medical supervision, with your prescriber monitoring your response and adjusting your protocol as needed.
What to Expect When Starting
Most people are advised to begin with a consistent daily schedule for at least eight to twelve weeks before evaluating results, since growth hormone-related changes in body composition and recovery build gradually rather than overnight. Sleep quality is often the first noticeable change, followed by improvements in recovery time and, over a longer window, shifts in body composition when paired with consistent training and nutrition. Your prescriber can help set realistic milestones and adjust your plan if you're not seeing the expected response.
Frequently Asked Questions
What's the difference between CJC-1295 and Ipamorelin?
CJC-1295 stimulates the pituitary to produce growth hormone, while Ipamorelin triggers its release. They're combined because they act on complementary steps of the same process.
When should CJC-1295/Ipamorelin be injected?
Most protocols recommend evening or bedtime dosing to align with the body's natural overnight growth hormone release pattern, but your prescriber will confirm the best schedule for you.
How long before I notice results?
Many people report improved sleep quality within the first one to two weeks, with changes in body composition typically becoming more noticeable over eight to twelve weeks of consistent use.
Is this combination suitable for everyone?
Not necessarily. Suitability depends on your health history and goals. A consultation with your prescriber ensures it's appropriate for you before starting.
Book Your Consultation
Ready to find out if CJC-1295 & Ipamorelin is right for you? Start your journey!